1IA
OGN icon

1620 Investment Advisors’s Organon & Co OGN Stock Holding History

1620 Investment Advisors’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-75
Closed -$801 – 670
2025
Q3 		$801 Hold
75
– – ﹤0.01% 616
2025
Q2 		$726 Hold
75
– – ﹤0.01% 644
2025
Q1 		$1.12K Hold
75
– – ﹤0.01% 621
2024
Q4 		$1.12K Hold
75
– – ﹤0.01% 626
2024
Q3 		$1.44K Hold
75
– – ﹤0.01% 587
2024
Q2 		$1.55K Buy
+75
New +$1.49K ﹤0.01% 557

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
KBG
Kahn Brothers Group New York $633M AUM 39.01% 1-Year Est. Return

1620 Investment Advisors's OGN Position: Q4 2025 in Review

1620 Investment Advisors sold out of Organon & Co (OGN) in Q4 2025, closing a stake of 75 shares — an estimated $801 sold.

1620 Investment Advisors first reported a position in OGN in Q2 2024 and held it in 6 quarters. The position peaked at $1.55K in Q2 2024. 634 funds tracked by Wall St. Rank hold OGN as of Q4 2025.

  • 1620 Investment Advisors reported no remaining Organon & Co position as of Q4 2025 after selling out during the quarter.
  • 1620 Investment Advisors sold 75 Organon & Co shares in Q4 2025, an estimated $801.
  • 1620 Investment Advisors first reported a position in Organon & Co in Q2 2024 and held it in 6 quarters.
  • 1620 Investment Advisors's Organon & Co position peaked at $1.55K in Q2 2024.
  • 634 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.

Based on 1620 Investment Advisors's 13F filing for Q4 2025, filed 5 Feb 2026.